Doximity (NASDAQ:DOCS) Price Target Raised to $43.00 at Wells …

1 day ago · Doximity (NASDAQ:DOCS – Free Report) had its price target boosted by Wells Fargo & Company from $41.00 to $43.00 in a research note published on Monday,Benzinga …

$43.00
OFF

Doximity (NASDAQ:DOCS) Price Target Raised To $43.00 At Wells …

2 weeks from now

1 day ago · Doximity (NASDAQ:DOCS – Free Report) had its price target boosted by Wells Fargo & Company from $41.00 to $43.00 in a research note published on Monday,Benzinga …

etfdailynews.com

$43
OFF

Doximity Price Target Raised To $43 From $41 At Wells Fargo

2 weeks from now

2 days ago · Wells Fargo analyst Stan Berenshteyn raised the firm’s price target on Doximity (DOCS) to $43 from $41 as estimates positioned for potential near-term upside. But upside to …

businessinsider.com

$54.00
OFF

Wells Fargo & Company Issues Positive Forecast For Doximity …

2 weeks from now

1 day ago · Bank of America raised their price target on Doximity from $54.00 to $57.00 and gave the stock a "neutral" rating in a research note on Monday, January 6th. The Goldman Sachs …

marketbeat.com

$613000
OFF

FNY Investment Advisers LLC Makes New $613,000 Investment In …

2 weeks from now

22 hours ago · FNY Investment Advisers LLC purchased a new stake in Doximity, Inc. (NASDAQ:DOCS - Free Report) during the fourth quarter, according to the company in its …

marketbeat.com

5%
OFF

Doximity (NASDAQ:DOCS) Trading Down 5% - What's Next?

2 weeks from now

Dec 30, 2024 · They issued an "equal weight" rating and a $55.00 price target for the company. Finally, Wells Fargo & Company raised Doximity from an "underweight" rating to an "equal …

marketbeat.com

$45
OFF

Doximity, Inc.: Target Price Consensus And Analysts …

2 weeks from now

Jan 8, 2025 · Baird Adjusts Doximity Price Target to $45 From $41, Maintains Outperform Rating 24-09-17: MT Analyst recommendations: Biogen, Cloudflare, Doordash, Moderna, Diageo...

marketscreener.com

$55.13
OFF

Demystifying Doximity: Insights From 15 Analyst Reviews

2 weeks from now

1 day ago · In the assessment of 12-month price targets, analysts unveil insights for Doximity, presenting an average target of $55.13, a high estimate of $75.00, and a low estimate of $33.00.

nasdaq.com

$53.94
OFF

What Is The Current Price Target And Forecast For Doximity (DOCS)

2 weeks from now

Jan 7, 2025 · Based on short-term price targets offered by 18 analysts, the average price target for Doximity comes to $53.94. The forecasts range from a low of $31.00 to a high of $75.00.

zacks.com

$53.50
OFF

Doximity Reaches Analyst Target Price - Nasdaq

2 weeks from now

Dec 4, 2024 · In recent trading, shares of Doximity Inc (Symbol: DOCS) have crossed above the average analyst 12-month target price of $53.50, changing hands for $54.20/share. When a …

nasdaq.com

$53.00
OFF

Doximity (DOCS) Stock Forecast And Price Target 2025 - MarketBeat

2 weeks from now

5 days ago · According to the 20 analysts' twelve-month price targets for Doximity, the average price target is $53.00. The highest price target for DOCS is $75.00, while the lowest price …

marketbeat.com

$57
OFF

Doximity Price Target Raised To $57 From $54 At BofA - Nasdaq

2 weeks from now

Jan 6, 2025 · BofA analyst Allen Lutz raised the firm’s price target on Doximity (DOCS) to $57 from $54 and keeps a Neutral rating on the shares. The firm believes that Doximity should …

nasdaq.com

5%
OFF

Doximity (NASDAQ:DOCS) Trading Down 5% – What’s Next?

2 weeks from now

Dec 30, 2024 · They issued an “equal weight” rating and a $55.00 price target for the company. Finally, Wells Fargo & Company raised Doximity from an “underweight” rating to an “equal …

tickerreport.com

13%
OFF

Doximity (DOCS) Stock Price, News & Analysis - MarketBeat

2 weeks from now

2 days ago · Doximity price target raised to $57 from $54 at BofA. January 7, 2025 | markets.businessinsider.com. Doximity (DOCS) Stock Moves -0.13%: What You Should …

marketbeat.com

$60
OFF

Doximity Price Target Raised To $60 From $35 At Leerink

2 weeks from now

Nov 8, 2024 · Leerink raised the firm’s price target on Doximity (DOCS) to $60 from $35 and keeps a Market Perform rating on the shares. The company’s Q2 earnings came in well above …

nasdaq.com

9%
OFF

Doximity (NASDAQ:DOCS) Trading 4.9% Higher - Should You Buy?

2 weeks from now

Dec 19, 2024 · They issued a "neutral" rating and a $55.00 price objective for the company. Finally, Wells Fargo & Company upgraded Doximity from an "underweight" rating to an "equal …

marketbeat.com

$75
OFF

Doximity Price Target Raised To $75 From $52 At Barclays

2 weeks from now

Nov 11, 2024 · Barclays raised the firm’s price target on Doximity (DOCS) to $75 from $52 and keeps an Overweight rating on the shares. The company reported a strong fiscal Q2 that …

nasdaq.com

$57.00
OFF

Doximity (NASDAQ:DOCS) Given New $57.00 Price Target At

2 weeks from now

Jan 6, 2025 · The Goldman Sachs Group started coverage on Doximity in a report on Friday, November 15th. They set a "neutral" rating and a $58.00 price objective on the stock. Finally, …

marketbeat.com

$65.00
OFF

Doximity (NASDAQ:DOCS) Given New $65.00 Price Target At …

2 weeks from now

6 days ago · Doximity (NASDAQ:DOCS - Get Free Report) had its target price cut by analysts at KeyCorp from $70.00 to $65.00 in a research note issued to investors on …

marketbeat.com

FAQs about Doximity (NASDAQ:DOCS) Price Target Raised to $43.00 at Wells … Coupon?

What is the target price for Doximity stock?

According to 5 Wall Street analysts, the average 1-year price target for Doximity (DOCS) stock is $36.80. The highest DOCS stock price forecast is $45.00, while the lowest DOCS stock price forecast is $29.00. ...

How much did Doximity (Docs) raise in an IPO?

Doximity (DOCS) raised $501 million in an initial public offering on Thursday, June 24th 2021. The company issued 23,300,000 shares at a price of $20.00-$23.00 per share. Morgan Stanley, Goldman Sachs and J.P. Morgan Securities served as the underwriters for the IPO and Piper Sandler, William Blair, Canaccord and Raymond James were co-managers. ...

Where can I buy Doximity stock?

Shares of DOCS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Doximity own? ...

Doximity insiders buy or sell a company stock?

In the past three months, Doximity insiders have not sold or bought any company stock. 37.40% of the stock of Doximity is held by insiders. A high percentage of insider ownership can be a sign of company health. 87.19% of the stock of Doximity is held by institutions. ...

Is Doximity's accelerated growth here to stay?

Following the company's revenue growth decelerating from over 90% in 2021 to just 6% only two quarters ago, the market seems optimistic that Doximity's accelerated growth could be here to stay. ...

Where is Doximity based?

It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California. Read More… ...